ÌÇÐÄvlog

[Skip to Navigation]
Sign In

October 2024 - July 1959

Decade

Year

Issue

May 2019, Vol 76, No. 5, Pages 459-550

In This Issue of JAMA Psychiatry

Highlights

Abstract Full Text
free access
JAMA Psychiatry. 2019;76(5):459. doi:10.1001/jamapsychiatry.2018.2980
Viewpoint

Psychiatry’s Opportunity to Prevent the Rising Burden of Age-Related Disease

Abstract Full Text
JAMA Psychiatry. 2019;76(5):461-462. doi:10.1001/jamapsychiatry.2019.0037

This Viewpoint discusses the role of psychiatry in preventing the population-wide burden of age-related disease.

Editorial

JAMA Psychiatry—The Year in Review, 2018

Abstract Full Text
free access
JAMA Psychiatry. 2019;76(5):463-464. doi:10.1001/jamapsychiatry.2019.0216

Suicide Reduction and Research Efforts in Service Members and Veterans—Sobering Realities

Abstract Full Text
JAMA Psychiatry. 2019;76(5):464-466. doi:10.1001/jamapsychiatry.2018.4564

Reframing the Suicide Prevention Message for Military Personnel

Abstract Full Text
JAMA Psychiatry. 2019;76(5):466-468. doi:10.1001/jamapsychiatry.2018.3943

Can Adjunctive Pharmacotherapy Reduce Hospitalization in Schizophrenia?Insights From Administrative Databases

Abstract Full Text
JAMA Psychiatry. 2019;76(5):468-470. doi:10.1001/jamapsychiatry.2018.4318

Progressing Polygenic Medicine in Psychiatry Through Electronic Health Records

Abstract Full Text
JAMA Psychiatry. 2019;76(5):470-472. doi:10.1001/jamapsychiatry.2018.3975

Pharmacologic Intervention for the Treatment and Prevention of Delirium: Looking Beneath the Modeling

Abstract Full Text
JAMA Psychiatry. 2019;76(5):472-473. doi:10.1001/jamapsychiatry.2018.4276
Original Investigation

Effect of Augmenting Standard Care for Military Personnel With Brief Caring Text Messages for Suicide Prevention: A Randomized Clinical Trial

Abstract Full Text
free access has audio
JAMA Psychiatry. 2019;76(5):474-483. doi:10.1001/jamapsychiatry.2018.4530

This randomized clinical trial tests the effectiveness of using a series of simple text messages sent over 12 months to reduce suicidal thoughts and behaviors in military service members experiencing current suicidal ideation or suicide risk incidents.

Effect of Developmentally Adapted Cognitive Processing Therapy for Youth With Symptoms of Posttraumatic Stress Disorder After Childhood Sexual and Physical Abuse: A Randomized Clinical Trial

Abstract Full Text
free access
JAMA Psychiatry. 2019;76(5):484-491. doi:10.1001/jamapsychiatry.2018.4349

This multicenter randomized clinical trial examines whether developmentally adapted cognitive processing therapy is more effective than a wait-list condition with treatment advice among adolescents with symptoms of posttraumatic stress disorder related to childhood sexual and/or physical abuse.

Association of the Youth-Nominated Support Team Intervention for Suicidal Adolescents With 11- to 14-Year Mortality Outcomes: Secondary Analysis of a Randomized Clinical Trial

Abstract Full Text
free access
JAMA Psychiatry. 2019;76(5):492-498. doi:10.1001/jamapsychiatry.2018.4358

This secondary analysis of a randomized clinical trial compared mortality among suicidal adolescents who received a psychoeducational social support suicide prevention intervention with that among suicidal adolescents who received treatment as usual.

Association of Antipsychotic Polypharmacy vs Monotherapy With Psychiatric Rehospitalization Among Adults With Schizophrenia

Abstract Full Text
open access
JAMA Psychiatry. 2019;76(5):499-507. doi:10.1001/jamapsychiatry.2018.4320

This national cohort study examines the use of polypharmacy vs monotherapy as maintenance treatment among adult patients with schizophrenia who have been rehospitalized for psychiatric treatment in Finland.

Comparative Effectiveness of Adjunctive Psychotropic Medications in Patients With Schizophrenia

Abstract Full Text
free access
JAMA Psychiatry. 2019;76(5):508-515. doi:10.1001/jamapsychiatry.2018.4489

This cohort study uses US national Medicaid data to compare the effectiveness of different psychotropic medication strategies (antidepressant, benzodiazepine, mood stabilizer, or another antipsychotic) for adult patients with schizophrenia who are receiving antipsychotic treatment.

Association of Polygenic Liabilities for Major Depression, Bipolar Disorder, and Schizophrenia With Risk for Depression in the Danish Population

Abstract Full Text
free access
JAMA Psychiatry. 2019;76(5):516-525. doi:10.1001/jamapsychiatry.2018.4166

This cohort study explores the association of polygenic risk scores for major depression, bipolar disorder, and schizophrenia with the risk for depression in the Danish population.

Association of Delirium Response and Safety of Pharmacological Interventions for the Management and Prevention of Delirium: A Network Meta-analysis

Abstract Full Text
free access
JAMA Psychiatry. 2019;76(5):526-535. doi:10.1001/jamapsychiatry.2018.4365

This network meta-analysis evaluates evidence regarding pharmacological interventions for delirium treatment and prevention.

Association of Fetal Growth With General and Specific Mental Health Conditions

Abstract Full Text
open access
JAMA Psychiatry. 2019;76(5):536-543. doi:10.1001/jamapsychiatry.2018.4342

This register-based study of pairs of siblings examines the associations between fetal growth and general and specific mental health conditions, controlling for familial factors.

Research Letter

Association of Early-Life Stress With Cytomegalovirus Infection in Adults With Major Depressive Disorder

Abstract Full Text
free access
JAMA Psychiatry. 2019;76(5):545-547. doi:10.1001/jamapsychiatry.2018.4543

This study examines the association of cytomegalovirus infection in adults with major depressive disorder who experienced various forms of childhood stress.

Comment & Response

Autism Risk and Serotonin Reuptake Inhibitors

Abstract Full Text
JAMA Psychiatry. 2019;76(5):547-548. doi:10.1001/jamapsychiatry.2019.0073

Autism Risk and Serotonin Reuptake Inhibitors—Reply

Abstract Full Text
JAMA Psychiatry. 2019;76(5):548-549. doi:10.1001/jamapsychiatry.2019.0081

Notice of Retraction and Replacement: Ecker et al. Association between the probability of autism spectrum disorder and normative sex-related phenotypic diversity in brain structure. JAMA Psychiatry. 2017;74(4):329-338

Abstract Full Text
JAMA Psychiatry. 2019;76(5):549-550. doi:10.1001/jamapsychiatry.2018.4296

Notice of Retraction and Replacement: Ecker et al. Association between the probability of autism spectrum disorder and normative sex-related phenotypic diversity in brain structure. JAMA Psychiatry. 2017;74(4):329-338

Correction

Error in Byline

Abstract Full Text
free access
JAMA Psychiatry. 2019;76(5):550. doi:10.1001/jamapsychiatry.2019.0618
Peer Reviewers List

JAMA Psychiatry Peer Reviewers in 2018

Abstract Full Text
free access online only
JAMA Psychiatry. 2019;76(5):e190124. doi:10.1001/jamapsychiatry.2019.0124
JAMA Psychiatry Masthead

JAMA Psychiatry

Abstract Full Text
free access
JAMA Psychiatry. 2019;76(5):460. doi:10.1001/jamapsychiatry.2018.2981
×